Stay updated on Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a 'Results Submitted' status and updated the page to Revision: v3.4.2, replacing the prior 'No Results Posted' notice and the earlier v3.4.1 revision.SummaryDifference0.3%

- Check42 days agoChange DetectedAdded a government funding notice about potential delays and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedIntroduced a glossary toggle and added display of QC-related fields (Last Update Submitted that Met QC Criteria and Last Update Posted) along with No FEAR Act Data and a new Revision: v3.4.0. Older labels such as Last Update Submitted that met QC Criteria and Last Update Posted (Estimated) were removed or renamed.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision: v3.3.4 is shown on the page, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedTwo new publications are added under Publications, citing Lancet Oncology papers on tiragolumab plus atezolizumab with chemotherapy for unresectable or metastatic esophageal cancer; the items appear to be auto-filled from PubMed.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.